Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15569797 | 0.91 | — | — | |
| SCHEMBL31119405 | 0.88 | — | — | |
| SCHEMBL961347 | 0.85 | ALDH1A1 (0.33) | TSHR | |
| SCHEMBL15502143 | 0.85 | — | — | |
| SCHEMBL9880240 | 0.84 | — | — | |
| SCHEMBL577857 | 0.83 | — | — | |
| SCHEMBL10301172 | 0.83 | — | — | |
| SCHEMBL10005279 | 0.83 | — | — | |
| SCHEMBL13621783 | 0.83 | — | — | |
| SCHEMBL10301165 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170202756-A1 | Fibrous Support Comprising Particles Containing a Partially Water-Soluble Active Agent, Particles, and Methods for Producing Said Particles | SATISLOH AG (CH) | 2017-07-20 | — | — | US | disclosed |
| US-20150366421-A1 | DRY WIPE WITH DEMISTING AND/OR CLEANING ACTION | SATISLOH AG (CH) | 2015-12-24 | — | — | US | disclosed |
| US-20100303748-A1 | METHOD FOR LIGHTENING AND/OR COLORING HUMAN KERATIN FIBERS USING A COMPOSITION COMPRISING AN AMINOTRIALKOXY SILANE OR AMINOTRIALKENYLOXY SILANE COMPOUND AND DEVICE | L'OREAL S.A. (FR) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100303748-A1 | METHOD FOR LIGHTENING AND/OR COLORING HUMAN KERATIN FIBERS USING A COMPOSITION COMPRISING AN AMINOTRIALKOXY SILANE OR AMINOTRIALKENYLOXY SILANE COMPOUND AND DEVICE | KRT18, FABP4, APMAP | CA2 2613/4885CYP3A4 3173/4885TSHR 4700/4885 |
| US-20170202756-A1 | Fibrous Support Comprising Particles Containing a Partially Water-Soluble Active Agent, Particles, and Methods for Producing Said Particles | FIBP, MMP1, MFAP1 | CA2 2843/4885CYP3A4 4565/4885TSHR 4827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.